Perceived results v provable outcomes in skincare
The ban of a high-profile campaign like Eucerin’s Hyaluron-Filler Epigenetic Serum—reported by BBC News—isn’t just a regulatory footnote. It highlights a structural issue within the skincare industry: the gap between perceived results and provable outcomes.
Here’s the uncomfortable truth—skincare efficacy is, to a significant extent, subjective.
Consumers don’t experience formulations in a vacuum. They interpret results through a mix of:
- expectation (what they’ve been told it should do)
- sensory cues (texture, absorption rate, fragrance, finish)
- branding and price anchoring
- time investment and routine consistency
This creates a powerful cognitive overlay where perception often precedes evidence.
From a formulation standpoint, we know that:
- Many topically applied actives—whether hyaluronic acid, peptides, or botanical extracts—operate within relatively modest biological limits in vivo.
- Changes in skin hydration, smoothness, or luminosity can be real, but are often incremental and transient, not transformational.
- The skin’s condition is influenced as much by sleep, environment, and barrier integrity as by any single product.
Yet marketing narratives routinely escalate these subtle effects into definitive claims—“restructuring”, “reprogramming”, “epigenetic renewal”—language that implies a level of biological control that simply isn’t substantiated in cosmetic science.
That’s where regulation steps in. Not to suppress innovation, but to enforce a baseline:
claims must be evidence-based, reproducible, and not misleading.
For those of us formulating or building brands, this moment is a useful checkpoint.
It challenges us to:
- communicate benefits with precision rather than exaggeration
- respect the difference between cosmetic improvement and clinical change
- educate consumers on what skincare can realistically achieve
Because in the long term, credibility compounds far more effectively than hyperbole.
The irony is that many well-formulated, plant-based products—lightweight, bioavailable, barrier-supportive—deliver excellent results. Just not always in the dramatic, immediate way consumers have been conditioned to expect.
And perhaps that’s the shift we need:
From selling transformation,
to explaining function.
Whatsapp us!